Global Patent Index - EP 1351629 A2

EP 1351629 A2 20031015 - PROSTHESES AND INSTRUMENTATION FOR JOINT REPLACEMENT AND REPAIR

Title (en)

PROSTHESES AND INSTRUMENTATION FOR JOINT REPLACEMENT AND REPAIR

Title (de)

PROTHESEN UND INSTRUMENTE FÜR GELENKERSATZ UND ?REPARATUR

Title (fr)

PROTHESES ET INSTRUMENTS PERMETTANT LE REMPLACEMENT ET LA REPARATION D'ARTICULATIONS

Publication

EP 1351629 A2 20031015 (EN)

Application

EP 02709049 A 20020116

Priority

  • US 0201178 W 20020116
  • US 76122701 A 20010116

Abstract (en)

[origin: WO02067811A2] The present invention relates to a prostheses and instrumentation for joint repair and replacement. In a transosseous core approach of the present invention, the joint is entered through a pathway provided in a portion of a joint bone. Such pathway is preferably made by taking out a bone core form the bone in or adjacent to the joint, wherever possible without substantially compromising physical integrity and physiological viability of the joint. Typically the main route for the transosseous core approach traverses through a more-accessible bone of the joint which can be aligned with a less-accessible bone of the joint in order to facilitate treatment of articular surfaces and/or other structures in the joint. The transosseous pathway into the joint is preferably provided by novel surgical instruments such as a core cutter, cartilage punch, hemostatic device, and retractable axial/transaxial cutting device. Implants modules are also provided which can be inserted into the joint through the transosseous pathway and assembled in situ inside the joint to form an implant assembly.

[origin: WO02067811A2] The present invention relates to a prostheses and instruments for joint repair and replacement. In a transosseous core approach of the present invention, the joint is entered through a pathway provided in a portion of a joint bone. Such pathway is preferably made by taking out a bone core from the bone in or adjacent to the joint, wherever possible without substantially compromising physical integrity and physiological viability of the joint. Typically the main route for the transosseous core with a less-accessible bone of the joint in order to facilitate treatment of articular surfaces and/or other structures in the joint. The transosseous pathway into the joint is preferably provided by novel surgical instruments such as a core cutter (30), cartilage punch (40), hemostatic device (60) and retractable axial/transaxial cutting device (33). Implants modules are also provided which can be inserted into the joint through the transosseous pathway and assembled in situ inside the joint to form an implant assembly.

IPC 1-7

A61F 2/30

IPC 8 full level

A61B 17/56 (2006.01); A61B 17/12 (2006.01); A61B 17/16 (2006.01); A61B 17/17 (2006.01); A61F 2/30 (2006.01); A61F 2/32 (2006.01); A61F 2/40 (2006.01); A61F 2/46 (2006.01); A61B 17/86 (2006.01); A61F 2/00 (2006.01); A61F 2/34 (2006.01); A61F 2/36 (2006.01); A61F 2/38 (2006.01); A61F 2/42 (2006.01)

CPC (source: EP US)

A61B 17/1604 (2013.01 - EP US); A61B 17/1617 (2013.01 - EP US); A61B 17/1637 (2013.01 - EP US); A61B 17/1668 (2013.01 - EP US); A61B 17/1684 (2013.01 - EP US); A61B 17/175 (2013.01 - EP US); A61B 17/1778 (2016.10 - EP US); A61F 2/32 (2013.01 - EP US); A61F 2/4014 (2013.01 - EP US); A61F 2/4081 (2013.01 - EP US); A61F 2/4612 (2013.01 - EP US); A61B 17/1662 (2013.01 - EP US); A61B 17/86 (2013.01 - EP US); A61F 2/30767 (2013.01 - EP US); A61F 2/36 (2013.01 - EP US); A61F 2/38 (2013.01 - EP US); A61F 2/3804 (2013.01 - EP US); A61F 2/40 (2013.01 - EP US); A61F 2/4202 (2013.01 - EP US); A61F 2/4225 (2013.01 - EP US); A61F 2/4241 (2013.01 - EP US); A61F 2/4261 (2013.01 - EP US); A61F 2002/30079 (2013.01 - EP US); A61F 2002/30121 (2013.01 - EP US); A61F 2002/30224 (2013.01 - EP US); A61F 2002/30299 (2013.01 - EP US); A61F 2002/30354 (2013.01 - EP US); A61F 2002/30387 (2013.01 - EP US); A61F 2002/3055 (2013.01 - EP US); A61F 2002/30599 (2013.01 - EP US); A61F 2002/30604 (2013.01 - EP US); A61F 2002/3065 (2013.01 - EP US); A61F 2002/30677 (2013.01 - EP US); A61F 2002/30685 (2013.01 - EP US); A61F 2002/30787 (2013.01 - EP US); A61F 2002/3082 (2013.01 - EP US); A61F 2002/3085 (2013.01 - EP US); A61F 2002/30873 (2013.01 - EP US); A61F 2002/30878 (2013.01 - EP US); A61F 2002/30934 (2013.01 - EP US); A61F 2002/3414 (2013.01 - EP US); A61F 2002/3448 (2013.01 - EP US); A61F 2002/3611 (2013.01 - EP US); A61F 2002/3625 (2013.01 - EP US); A61F 2002/365 (2013.01 - EP US); A61F 2002/4018 (2013.01 - EP US); A61F 2002/4635 (2013.01 - EP US); A61F 2002/4687 (2013.01 - EP US); A61F 2210/009 (2013.01 - EP US); A61F 2220/0025 (2013.01 - EP US); A61F 2220/0033 (2013.01 - EP US); A61F 2230/0006 (2013.01 - EP US); A61F 2230/0069 (2013.01 - EP US); A61F 2230/0093 (2013.01 - EP US); A61F 2250/0063 (2013.01 - EP US); A61F 2310/00011 (2013.01 - EP US); A61F 2310/00179 (2013.01 - EP US)

Citation (search report)

See references of WO 02067811A2

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 02067811 A2 20020906; WO 02067811 A3 20030320; CA 2435662 A1 20020906; EP 1351629 A2 20031015; JP 2004522537 A 20040729; US 2002095214 A1 20020718; US 2002111689 A1 20020815; US 2002111690 A1 20020815; US 2002133153 A1 20020919; US 2002138148 A1 20020926; US 2002138149 A1 20020926; US 2006142865 A1 20060629; US 6589281 B2 20030708; US 6716249 B2 20040406; US 6783548 B2 20040831; US 6984248 B2 20060110

DOCDB simple family (application)

US 0201178 W 20020116; CA 2435662 A 20020116; EP 02709049 A 20020116; JP 2002567186 A 20020116; US 14767402 A 20020516; US 14767602 A 20020516; US 14773102 A 20020516; US 28934205 A 20051128; US 5723702 A 20020124; US 5723802 A 20020124; US 76122701 A 20010116